---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-087486"
form_type: "8-K"
ticker: "TRVI"
cik: "0001563880"
company_name: "Trevi Therapeutics, Inc."
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T04:35:10.605596+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Trevi shareholders approve 6M share increase for 2019 Stock Incentive Plan

## Summary
- Stockholders voted to increase authorized shares under the 2019 Plan by 6,000,000 shares.
- Class III directors Jennifer Good and Anne VanLent re-elected with 78.8M and 62.9M votes for, respectively.
- Ratification of Ernst & Young as auditor for FY2025 passed with 88.9M votes for.
- Advisory say-on-pay approved (78.3M for, 0.7M against); future votes will be held every year.
- All proposals, including the equity plan amendment, received required majority approval.

## SEC filing metadata
- accession: 0000950170-25-087486
- form_type: 8-K
- ticker: TRVI
- cik: 0001563880
- company_name: Trevi Therapeutics, Inc.
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563880/000095017025087486/0000950170-25-087486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563880/000095017025087486/trvi-20250611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-087486
- JSON: https://secwatch.observer/filing/0000950170-25-087486.json
- Plain text: https://secwatch.observer/filing/0000950170-25-087486.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.